Ali Zafar1, Mohammed Mustafa, Mark Chapman. 1. Department of General and Colorectal Surgery, Good Hope Hospital, Heart of England NHS Trust, Rectory Road, Sutton Coldfield, West Midlands, B75 7RR, UK. ali.zafar@nhs.net
Abstract
BACKGROUND: Current guidelines recommend tattooing of suspicious-looking lesions at colonoscopy without a reference to the size of the polyp. However, the endoscopist has to make a judgement as to which lesion may be malignant and require future localisation based on the appearance and size of the polyp. The aim of this study was to determine the relationship between endoscopic polyp size and invasive colorectal cancer so as to inform tattooing practice for patients taking part in the national bowel cancer screening programme (BCSP). METHODS: Data of BCSP patients who had undergone a polypectomy between October 2008 and October 2010 were collected from a prospectively maintained hospital endoscopic database. Histology data were obtained from electronic patient records. RESULTS: A total of 165 patients had undergone 269 polypectomies. Their median age was 66 years and 66 % were men. The mean endoscopic polyp size was 10.7 mm (SD = ± 8 mm). Histologically, 81 % were neoplastic with 95 % showing low-grade and 5 % high-grade dysplasia. Eight patients were found to have invasive malignancy within their polyp. The risk of invasive malignancy within a polyp was 0.7 % (1/143) when the endoscopic polyp size was <10 mm; the risk increased to 2.4 % (2/83) when the polyp size was 10-19 mm and 13 % (5/40) when the polyp was >20 mm. This trend was statistically significant (p = 0.001). About 23 % of the patients had the site of their polyp tattooed; the mean size of the tattooed polyps was 21 mm (range = 15-50 mm). Consequently, 25 % of malignant polyps and 63 % of polyps with high-grade dysplasia were not tattooed. CONCLUSION: The risk of polyp cancer among BCSP patients increases significantly when the endoscopic polyp size is ≥ 10 mm. We recommend that all polyps ≥ 10 mm be tattooed.
BACKGROUND: Current guidelines recommend tattooing of suspicious-looking lesions at colonoscopy without a reference to the size of the polyp. However, the endoscopist has to make a judgement as to which lesion may be malignant and require future localisation based on the appearance and size of the polyp. The aim of this study was to determine the relationship between endoscopic polyp size and invasive colorectal cancer so as to inform tattooing practice for patients taking part in the national bowel cancer screening programme (BCSP). METHODS: Data of BCSP patients who had undergone a polypectomy between October 2008 and October 2010 were collected from a prospectively maintained hospital endoscopic database. Histology data were obtained from electronic patient records. RESULTS: A total of 165 patients had undergone 269 polypectomies. Their median age was 66 years and 66 % were men. The mean endoscopic polyp size was 10.7 mm (SD = ± 8 mm). Histologically, 81 % were neoplastic with 95 % showing low-grade and 5 % high-grade dysplasia. Eight patients were found to have invasive malignancy within their polyp. The risk of invasive malignancy within a polyp was 0.7 % (1/143) when the endoscopic polyp size was <10 mm; the risk increased to 2.4 % (2/83) when the polyp size was 10-19 mm and 13 % (5/40) when the polyp was >20 mm. This trend was statistically significant (p = 0.001). About 23 % of the patients had the site of their polyp tattooed; the mean size of the tattooed polyps was 21 mm (range = 15-50 mm). Consequently, 25 % of malignant polyps and 63 % of polyps with high-grade dysplasia were not tattooed. CONCLUSION: The risk of polyp cancer among BCSP patients increases significantly when the endoscopic polyp size is ≥ 10 mm. We recommend that all polyps ≥ 10 mm be tattooed.
Authors: J W Park; D K Sohn; C W Hong; K S Han; D H Choi; H J Chang; S-B Lim; H S Choi; S-Y Jeong Journal: Surg Endosc Date: 2007-08-17 Impact factor: 4.584
Authors: Arash Azin; M Carolina Jimenez; Michelle C Cleghorn; Timothy D Jackson; Allan Okrainec; Peter G Rossos; Fayez A Quereshy Journal: Can J Surg Date: 2016-02 Impact factor: 2.089
Authors: Michal F Kaminski; Siwan Thomas-Gibson; Marek Bugajski; Michael Bretthauer; Colin J Rees; Evelien Dekker; Geir Hoff; Rodrigo Jover; Stepan Suchanek; Monika Ferlitsch; John Anderson; Thomas Roesch; Rolf Hultcranz; Istvan Racz; Ernst J Kuipers; Kjetil Garborg; James E East; Maciej Rupinski; Birgitte Seip; Cathy Bennett; Carlo Senore; Silvia Minozzi; Raf Bisschops; Dirk Domagk; Roland Valori; Cristiano Spada; Cesare Hassan; Mario Dinis-Ribeiro; Matthew D Rutter Journal: United European Gastroenterol J Date: 2017-03-16 Impact factor: 4.623
Authors: Laura M Fernandez; Rowaa N M Ibrahim; Ido Mizrahi; Giovanna DaSilva; Steven D Wexner Journal: Surg Endosc Date: 2018-08-17 Impact factor: 4.584
Authors: Garrett G R J Johnson; Harminder Singh; Ashley Vergis; Jason Park; Olivia Hershorn; David Hochman; Ramzi M Helewa Journal: Surg Endosc Date: 2021-06-08 Impact factor: 4.584
Authors: Inge Stegeman; Sascha van Doorn; Rosalie Mallant-Hent; Manon van der Vlugt; Marco Mundt; Paul Fockens; Patrick Bossuyt; Evelien Dekker Journal: Endosc Int Open Date: 2014-06-23
Authors: Manon van der Vlugt; Sascha Corrie van Doorn; Junfeng Wang; Barbara Aj Bastiaansen; Lowewijk Aa Brosens; Paul Fockens; Evelien Dekker Journal: Endosc Int Open Date: 2016-05-19